Clinical Trial Update: Haploidentical PBMC Transplant for Severe Congenital Anemias [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update concerns haploidentical peripheral blood mononuclear cell transplant for sickle cell anemia, conducted in Phase 1 and Phase 2, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Haploidentical PBMC transplant

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sickle Cell Anemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2019-10-14